← Back to Search

Dietary Supplement

Test Group 2 for Type 2 Diabetes

N/A
Waitlist Available
Research Sponsored by BioKier Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, day 1, during the treatment period at days 21, 42, and 63, and at end of treatment period, day 84
Awards & highlights

Study Summary

This trial will test the effects of a new drug, BKR-017, on people. The study will last for 15 weeks, and participants will take the drug twice a day.

Eligible Conditions
  • Type 2 Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, day 1, during the treatment period at days 21, 42, and 63, and at end of treatment period, day 84
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, day 1, during the treatment period at days 21, 42, and 63, and at end of treatment period, day 84 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in HOMA-IR
Secondary outcome measures
Changes in HbA1c
Changes in fasting glucose
Changes in fasting insulin
+2 more

Trial Design

4Treatment groups
Active Control
Placebo Group
Group I: Test Group 2Active Control1 Intervention
Group 2 will receive 84 days of 0.5 g of BKR-017 BID
Group II: Test Group 3Active Control1 Intervention
Group 3 will receive 84 days of 1.0 g of BKR-017 BID
Group III: Test Group 4Active Control1 Intervention
Group 4 will receive 84 days of 1.5 g of BKR-017 BID
Group IV: Test Group 1Placebo Group1 Intervention
Group 1 will receive 84 days of placebo BID

Find a Location

Who is running the clinical trial?

BioKier Inc.Lead Sponsor
3 Previous Clinical Trials
48 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research endeavor include participants aged 45 or older?

"This medical investigation is open to patients aged 18 years or older and not exceeding 70 years in age."

Answered by AI

What criteria must participants meet in order to qualify for this clinical trial?

"This clinical trial is accepting applicants aged 18 to 70 who have been diagnosed with type 2 diabetes mellitus. To qualify for the study, patients must already be under care from a healthcare provider or newly diagnosed with T2DM, agree to complete an 84-day testing period, and maintain their existing dietary and exercise habits as well as current prescription medications."

Answered by AI

Are any new participants being accepted at this time for the experiment?

"Contrary to expectation, this clinical trial is not presently searching for participants. Initially posted on April 18th 2021 and last updated October 7 2022, it has been superseded by 1564 other trials actively seeking new enrollees."

Answered by AI

Who else is applying?

What state do they live in?
North Carolina
How old are they?
65+
What site did they apply to?
Duke Clinical Research at Pickett Road
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Dose-Response Study to Evaluate the Effect of BKR-017 on Insulin Resistance and Other Metabolic Parameters in Type 2 Diabetes Patients
2021. "Dose-Response Study to Evaluate the Effect of BKR-017 on Insulin Resistance and Other Metabolic Parameters in Type 2 Diabetes Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04673656.
~15 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top